BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1017202)

  • 21. [Inhibitors of ovulation as inhibitors of proliferation].
    Kaiser R
    Geburtshilfe Frauenheilkd; 1973 Jan; 33(1):23-7. PubMed ID: 4119488
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium.
    Lüdicke F; Johannisson E; Helmerhorst FM; Campana A; Foidart J; Heithecker R
    Fertil Steril; 2001 Jul; 76(1):102-7. PubMed ID: 11438327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between pyridoxal phosphate and some synthetic oestrogens in their effect on kynurenine hydrolase and kynurenine aminotransferase enzymes of normal mouse liver.
    Saad AA; Abdel-Tawab GA; el-Zoghby SM; Mostafa MH; Moursi GE
    Biochem Pharmacol; 1974 Mar; 23(5):999-1013. PubMed ID: 4458682
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oral contraceptives on anions and cations of human cervical mucus.
    Singh EJ; Boss S
    Am J Obstet Gynecol; 1973 Aug; 116(7):1017-22. PubMed ID: 4718213
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the estrogenicity of various synthetic estrogens by means of vaginal hormonocytology].
    Teter J; Krzywdzinski K
    Rev Fr Endocrinol Clin; 1971; 12(1):9-20. PubMed ID: 4944905
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
    Arnold M; Tóth I; Faredin I
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
    [No Abstract]   [Full Text] [Related]  

  • 30. [Practical experience with a new contraceptive of the modified sequential type].
    Welti H
    Rev Med Suisse Romande; 1972 Oct; 92(10):785-95. PubMed ID: 4660891
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro effect of estrogens on the peroxidase activity of human endometrium.
    Okada H; Nawa M; Kimura J
    J Clin Endocrinol Metab; 1985 Sep; 61(3):404-7. PubMed ID: 2991317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian changes after long-term oral contraception.
    Plate WP
    Acta Endocrinol (Copenh); 1967 May; 55(1):71-7. PubMed ID: 6071598
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol.
    de la Pena A; Chenault CB; Goldzieher JW
    Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-ovulatory effects of ethinyl estradiol and mestranol, alone or in association with chlormadinone in the rabbit and rat].
    Chambon Y; Le Vève Y
    C R Seances Soc Biol Fil; 1966; 160(12):2411-5. PubMed ID: 4168071
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects, on the endometrium, of a new oral contraceptive: Physiostat].
    Delacroix P
    Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717
    [No Abstract]   [Full Text] [Related]  

  • 37. Endometrial control: a comparative study of three oral contraceptives.
    Talwar PP; Dingfelder JR; Ravenholt RT
    Int J Gynaecol Obstet; 1976; 14(5):385-9. PubMed ID: 15901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular parameters involved in the estrogenicity of mestranol and ethynylestradiol.
    Hahn DW; McGuire JL; Greenslade FC; Turner GD; DaVanzo JP
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1180-5. PubMed ID: 5138442
    [No Abstract]   [Full Text] [Related]  

  • 39. Decrease in endothelin-1 plasma levels during the menstrual cycle and after ethinylestradiol treatment.
    Merki-Feld GS; Keller PJ
    Ann Intern Med; 1999 Sep; 131(5):394. PubMed ID: 10475898
    [No Abstract]   [Full Text] [Related]  

  • 40. [Amenorrhea, anovulation and oligomenorrhea due to use of oral contraceptives].
    James M; Rozenbaum H
    Concours Med; 1974 Mar; 96(10):1559-60, 1563-4, 1567-8. PubMed ID: 4619979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.